Cooler temperatures impair the immune system, enhancing the seasonal spread of cold virus
the ONA take:
Yale School of Medicine researchers investigated the association between colds and cold-weather seasons. Their results can help oncology nurses advise their patients on avoiding these illnesses in colder temperatures.
Scientists have known that the rhinovirus replicates most effectively in the nose for more than 50 years. The question is why. This study revealed that the rhinovirus, the most frequent cause of the common cold, reproduces more efficiently in colder weather.
In addition, lower temperatures reduce the immune system, making our bodies less adept at stopping the virus. The nose is the most vulnerable spot because it is 8° to 9° cooler than the rest of the body and breathing further exposes it to frigid winter air.
The researchers examined airway cells taken from mice and kept at 98.6° or 91.4°, the average temperature in our nostrils.
Both the enzymes that detect viruses and the signals that connect those sensors to the immune system worked more effectively in the warmer temperature. The researchers suspect that other viruses may take advantage of the general suppression of the immune system that occurs in cooler temperatures as well.
Wearing a scarf, which can create a pocket of warm air around the nose while outside, may be an effective measure patients can take to avoid the common cold.
Yale researchers investigated the association between colds and cold-weather seasons.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Immunotherapy and the Future of Prostate Cancer Treatment
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Use of Checkpoint Inhibitors in Urothelial Carcinoma
- Chemo + Radiotherapy Efficacious in Muscle-invasive Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Colorectal Cancer Risk Higher With Poor Metabolic Health vs Increased Weight
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|